XML 46 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies

Schedule of allowance for credit losses

​

​	​	​	​	​	​	​
​	​	​	December 31,
​		​	2023		​	2022
Balance of allowance for credit losses, beginning of period	​	$	1,275	​	​	1,220
Change in expected credit losses	​	​	812	​	​	100
Write-offs, net of recoveries	​		(95)	​	​	(45)
Balance of allowance for credit losses, end of period	​	$	1,992	​	$	1,275

Schedule of disaggregation of revenue by major markets

​

​	​	​	​	​	​	​	​	​	​
​	​	December 31,
​		2023			2022			2021
Biopharma/Pharma	​	$	192,583	​	$	193,879	​	$	180,203
Animal Health	​		30,379	​		33,465	​		33,353
Reproductive Medicine	​	​	10,293	​	​	9,933	​	​	9,052
Total revenues	​	$	233,255	​	$	237,277	​	$	222,608

Schedule of geographical revenues, by origin

​

​	​	​	​	​	​	​	​	​	​
​	​	December 31,
​		2023			2022			2021
Americas	​	$	127,213	​	$	128,209	​	$	120,270
Europe, the Middle East, and Africa (EMEA)	​		60,883	​		66,913	​		59,334
Asia Pacific (APAC)	​		45,159	​		42,155	​		43,004
Total revenues	​	$	233,255	​	$	237,277	​	$	222,608

Schedule of amounts used in computing net loss per share

The following shows the amounts used in computing net loss per share (in thousands except per share data):

​

​	​	​	​	​	​	​	​	​	​
​	​	Year Ended December 31,
​		2023			2022			2021
Net loss	​	$	(99,587)	​	$	(37,333)	​	$	(275,528)
Paid-in-kind dividend on Series C convertible preferred stock	​		(8,000)	​		(8,000)	​		(8,196)
Net loss attributable to common shareholders	​	$	(107,587)	​	$	(45,333)	​	$	(283,724)
Weighted average common shares issued and outstanding - basic and diluted	​	​	48,737,377	​	​	48,987,295	​	​	45,927,591
Basic and diluted net loss per share	​	$	(2.21)	​	$	(0.93)	​	$	(6.18)

Schedule of the number of shares excluded from the computation of diluted loss per share

The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:

​

​	​	​	​	​	​	​
​	​	Years Ended December 31,
​		2023		2022		2021
Stock options	​	2,486,737		4,194,554		5,449,952
Restricted stock units	​	1,076,629	​	727,984	​	373,849
Series C convertible preferred stock	​	5,894,535	​	5,664,532	​	5,443,505
Convertible Senior Notes	​	3,756,437		4,022,734		4,022,734
​	​	13,214,338		14,609,804		15,290,040

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allowance for credit loss on accounts receivable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479319/326-20-50-13

+ Details

Name:	us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph a
-SubTopic 10
-Topic 280
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration